{"id":384,"date":"2026-09-17T05:02:06","date_gmt":"2026-09-17T05:02:06","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/dental-practice-sale-success-rate\/"},"modified":"2026-09-17T05:02:06","modified_gmt":"2026-09-17T05:02:06","slug":"dental-practice-sale-success-rate","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dental-practice-sale-success-rate\/","title":{"rendered":"Dental Practice Sale Success Rate: What Controls It"},"content":{"rendered":"<h2>Key Takeaways For Dental Practice Sellers<\/h2>\n<ul>\n<li>\n<p>The dental practice sale success rate breaks down into at least three distinct measures listing-to-close rate, valuation-achievement rate, and time-to-close and some sources also track LOI-to-close rate for the period after a letter of intent is signed.<\/p>\n<\/li>\n<li>\n<p>Professionally represented practices can reach transaction rates around the high-success cohort, compared with roughly 35\u201340% industry-wide and 15\u201320% for DIY sellers, because structured processes and competitive tension are controllable.<\/p>\n<\/li>\n<li>\n<p>Overpricing, single-buyer exposure, weak EBITDA documentation, and buyer financing collapse can be some of the main reasons deals fail after an LOI is signed.<\/p>\n<\/li>\n<li>\n<p>Correct pricing anchored to a diligence-grade valuation, a multi-buyer auction process, and pre-market preparation of financial documentation can move sellers into the higher-success group.<\/p>\n<\/li>\n<li>\n<p>McLerran &amp; Associates helps dental practice owners navigate these factors with a proven process; <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">learn what your practice is truly worth<\/a> with a confidential conversation.<\/p>\n<\/li>\n<\/ul>\n<h2>What The Dental Practice Sale Success Rate Actually Measures<\/h2>\n<p>The dental practice sale success rate is a composite of three distinct measures: the <strong>listing-to-close rate<\/strong> (the share of listed practices that reach a signed purchase agreement), the <strong>valuation-achievement rate<\/strong> (whether the final price holds the originally agreed figure through diligence), and <strong>time-to-close<\/strong> (how long the process takes from engagement to funded close). Conflating these three produces the contradictory figures owners encounter online. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.ada.org\/resources\/careers\/career-planning\/what-makes-a-successful-sale\">Reported dental practice sale figures vary widely by measure<\/a>. The ADA cites typical sales at 65\u201385% of the average of the last 3 years&#8217; collections. Broker sources report LOI-to-close rates as high as 95%. Conventional price\/gross ratios average around 61%.<\/p>\n<h2>What \u201cDental Practice Sale Success Rate\u201d Actually Means<\/h2>\n<p>Confusion around success-rate figures often begins with the fact that different sources measure different things. Three distinct metrics are commonly mixed together.<\/p>\n<ul>\n<li>\n<p><strong>Listing-to-close rate:<\/strong> The percentage of practices that, once listed, reach a funded close. Roughly 30% of signed letters of intent in lower-middle-market M&amp;A never reach close, with the rate rising to approximately 40% in SBA-financed deals under $1 million. Do-it-yourself sellers face close rates as low as 15\u201320%, while McLerran &amp; Associates reports a transaction rate of roughly 85\u201390% among its represented clients.<\/p>\n<\/li>\n<li>\n<p><strong>Valuation-achievement rate:<\/strong> Whether the agreed price survives diligence intact. About 85% of lower-middle-market deals face a post-letter-of-intent purchase-price adjustment, and almost all of those adjustments move the price downward. A high listing-to-close rate therefore does not automatically mean the seller walks away with the originally agreed number.<\/p>\n<\/li>\n<li>\n<p><strong>Time-to-close:<\/strong> How long the process takes. Doctor-to-doctor transactions typically close in 6 to 9 months, while DSO transactions can take 9 to 18 months because of private-equity diligence timelines and multi-document transaction packages.<\/p>\n<\/li>\n<\/ul>\n<p>The 95% close rate cited by Practice Exchange reflects its own LOI-to-close rate for dental practice sales. That figure describes deals that close once a Letter of Intent is signed, which Practice Exchange notes is well above the industry average and higher than DSO buyers&#8217; direct acquisition pipelines. That metric does not describe the broader listing-to-close rate across all sellers. The roughly 35\u201340% industry norm reflects the full population of listed practices, many of which are overpriced, underprepared, or exposed to a single buyer. Neither figure is a guarantee. Both are directional benchmarks shaped by the conditions under which the sale is run.<\/p>\n<h2>Why Dental Practice Sale Numbers Diverge So Widely<\/h2>\n<p>Three structural drivers can explain most of the gap between a 15% DIY close rate and an 85\u201390% professionally managed rate. These drivers are representation quality, pricing accuracy, and buyer pool size.<\/p>\n<p><strong>Representation quality<\/strong> shapes who controls the narrative around the practice&#8217;s profitability. A practice owner sells once in a career. A DSO negotiates acquisitions every week. Without a dental-specific sell-side advisor, the seller negotiates from a profound information disadvantage. The buyer, not the seller, sets the valuation anchor.<\/p>\n<p><strong>Pricing accuracy<\/strong> shapes whether buyer interest compounds or decays. An overpriced listing sits on the market. Buyer interest erodes. The practice eventually sells at a discount, if it sells at all. A correctly priced practice, backed by a diligence-grade EBITDA analysis (earnings before interest, taxes, depreciation, and amortization, the profitability metric institutional buyers use to price acquisitions), attracts serious buyers quickly.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<p><strong>Buyer pool size<\/strong> shapes whether competitive tension exists. Competitive processes can drive closes and push prices higher: a seller who talks to one buyer has one chance to close. A seller running a structured, multi-buyer process has many.<\/p>\n<p>McLerran &amp; Associates runs a structured, auction-like bid process that typically lasts 45 to 60 days and generates around 10 offers among a vetted pool of well-qualified buyers. That process can be the mechanism that moves a seller into the higher-success cohort.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<h2>Why Some Dental Practice Sales Fail After LOI<\/h2>\n<p>The following failure modes account for many deals that collapse after a letter of intent (LOI), the preliminary agreement that precedes a final purchase contract. Each has a specific mechanism, and each can be mitigated by professional sell-side representation. One item, poor buyer fit, describes a different type of failure, where the deal closes but the outcome disappoints.<\/p>\n<ul>\n<li>\n<p><strong>Overpricing:<\/strong> The listing sits on the market, buyer interest decays, and the practice eventually sells at a discount or fails to sell. Professional representation sets price to what the market will bear.<\/p>\n<\/li>\n<li>\n<p><strong>Single-buyer exposure:<\/strong> Lack of competitive tension means no fallback if the buyer walks and limited pressure to hold price. A structured multi-buyer process reduces this risk.<\/p>\n<\/li>\n<li>\n<p><strong>Weak EBITDA documentation:<\/strong> The buyer&#8217;s quality-of-earnings (QoE) team is hired to verify the seller&#8217;s profitability claims. If the documentation is weak, that team disallows add-backs and re-trades the deal down. Combined diligence findings accounted for approximately 46.6% of failed deals in the Axial 2025 Dead Deal Report, making diligence a major deal-killer cluster. A CPA-led valuation done before going to market helps defend against this.<\/p>\n<\/li>\n<li>\n<p><strong>Buyer financing collapse:<\/strong> SBA or bank financing falls through late in the process. Buyer financing collapse is the single most common fall-through trigger in sub-$10M deals, with 15\u201325% of SBA-financed LOIs ending because the buyer&#8217;s loan is denied or restructured. Vetting buyers for financial qualification before the LOI is signed can reduce this risk substantially.<\/p>\n<\/li>\n<li>\n<p><strong>Diligence re-trades:<\/strong> The agreed value does not hold under scrutiny. Roughly 30\u201340% of lower-middle-market deals are re-traded by 5\u201315% between LOI and close. Active quality-of-earnings defense, which means protecting the EBITDA figure when the buyer&#8217;s team pushes back, is the countermeasure.<\/p>\n<\/li>\n<li>\n<p><strong>Poor buyer fit:<\/strong> The deal may close, but staff, patients, or the seller&#8217;s legacy suffer, which is a failure of outcome rather than of closing. Vetting buyers for post-close reputation and operational approach, and blacklisting those with poor track records, protects what the seller has spent a career building.<\/p>\n<\/li>\n<\/ul>\n<h2>Controllable Factors That Move Your Dental Practice Sale Success Rate<\/h2>\n<p>The following levers sit largely within the seller&#8217;s control. Each connects directly to McLerran &amp; Associates&#8217; process and to its reported high transaction rate.<\/p>\n<ul>\n<li>\n<p><strong>Set price to the market.<\/strong> A correctly priced practice in the \u201cGoldilocks zone,\u201d where it attracts multiple serious buyers without leaving money on the table, forms the foundation of a successful process. McLerran&#8217;s CPA-led valuation establishes that number before the practice goes to market, which in turn makes the next lever, competition, possible.<\/p>\n<\/li>\n<li>\n<p><strong>Create competition.<\/strong> Once the price is credible, running a structured process among multiple vetted buyers generates the competitive tension described earlier that can hold price and accelerate close. McLerran&#8217;s auction-like bid process typically produces around 10 offers in 45 to 60 days.<\/p>\n<\/li>\n<li>\n<p><strong>Secure a diligence-grade valuation before going to market.<\/strong> A \u201cfree\u201d back-of-the-napkin valuation often becomes the quiet anchor that determines what the owner walks away with. A weak analysis tends to get re-traded in diligence. McLerran&#8217;s CPA-led EBITDA analysis is built to hold up under buyer scrutiny.<\/p>\n<\/li>\n<li>\n<p><strong>Vet buyers like investments.<\/strong> Every buyer should be evaluated for financial backing, management quality, and post-close reputation. McLerran reviews DSO capital sources and operating history and has blacklisted buyers known for poor post-close environments so those buyers never reach the table.<\/p>\n<\/li>\n<li>\n<p><strong>Prepare documentation and quality-of-earnings defense in advance.<\/strong> Every add-back, which is a discretionary or non-recurring expense added back to net income to show true profitability, must be documented and defensible before the buyer&#8217;s QoE team arrives. McLerran completes this work up front.<\/p>\n<\/li>\n<li>\n<p><strong>Choose representation that works both the private-buyer and DSO paths.<\/strong> McLerran works both transition pathways in roughly equal measure, doctor-to-doctor sales and DSO affiliations, giving owners a genuine side-by-side comparison that single-lane brokers cannot provide.<\/p>\n<\/li>\n<\/ul>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Discuss your practice, your goals, and which path serves you best<\/a> in a confidential call with McLerran &amp; Associates.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<h2>How Much Does A Successful Dental Practice Sell For?<\/h2>\n<p>Value is driven by fundamentals such as revenue, profitability, doctor count, expandability, revenue durability, and specialty demand. A fixed table cannot capture all of these. Two practices collecting the same annual revenue can be worth very different amounts depending on overhead, owner dependence, payer mix, and buyer type.<\/p>\n<p>As a broad orientation point, dental practices typically sell for 65%\u201385% of annual collections or 4x\u20137x EBITDA, or more for larger multi-doctor practices, according to 2026 market guidance. This range works as a sanity check rather than a full valuation. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/how-dental-practices-are-valued-2026\">The same practice can be valued 40\u201380% higher by a DSO buyer than by a private buyer<\/a>. The two buyer types use fundamentally different underwriting methods. Private buyers anchor on seller&#8217;s discretionary earnings (SDE), which is the total financial benefit a working owner derives from the practice. Institutional buyers anchor on EBITDA after replacing the owner&#8217;s clinical production at market-rate associate compensation.<\/p>\n<p>DSO and private-equity deals are typically valued as a multiple of EBITDA, with the multiple rising significantly with practice size and scale. Specialty shapes buyer demand and valuation in general terms. Some specialties command higher multiples and attract more competitive buyer interest than general dentistry, while others sit at the lower end of the range. McLerran &amp; Associates&#8217; CPA-led EBITDA analysis produces a diligence-grade valuation that holds up under buyer scrutiny. That type of number tends to resist re-trading when a buyer looks under the hood.<\/p>\n<p>Want to see how your practice measures against these benchmarks? <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Request a comprehensive practice valuation from McLerran &amp; Associates<\/a>.<\/p>\n<h2>DIY Dental Practice Sale Vs. Using A Broker Or Sell-Side Advisor<\/h2>\n<p>The representation model a seller chooses can be one of the largest determinants of outcome. The table below shows how transaction rates climb as representation becomes more specialized and competitive, from roughly 15\u201320% for DIY sellers to roughly 85\u201390% for a dental-only advisor running a structured auction. All figures are directional benchmarks drawn from industry sources and McLerran &amp; Associates&#8217; own transaction data.<\/p>\n<table style=\"min-width: 100px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Model<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Market Exposure<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Valuation Rigor<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Estimated Transaction Rate<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p><strong>DIY \/ For-Sale-By-Owner<\/strong><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>One buyer, no competitive tension, valuation set by the buyer<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>None, buyer-set anchor<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>~15\u201320%<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p><strong>Local Generalist Broker<\/strong><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Limited, typically 1\u20132 DSO relationships and a small local buyer list<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Weak, often a back-of-the-napkin number not built to survive diligence<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>~25\u201330%<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p><strong>Multi-Vertical Advisor<\/strong><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Broader, but buyer relationships spread across dental, veterinary, and other verticals<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Variable, deal experience present but dental-specific nuance limited<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>~30\u201335%<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p><strong>\u201cFree Valuation\u201d Lead-Generation Firm<\/strong><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Partial buyer list, over-promised number thrown against the wall<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Free, napkin-math that rarely survives diligence<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>~35\u201340% industry norm<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p><strong>McLerran &amp; Associates (Dental-Only Sell-Side Advisor)<\/strong><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Large premier private-buyer pool, vetted DSO and PE buyers, bad actors blacklisted, structured auction generating ~10 offers<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>CPA-led, diligence-grade EBITDA analysis built to hold under scrutiny and resist re-trading<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>~85\u201390% among McLerran&#8217;s clients<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>McLerran &amp; Associates is a dental-only sell-side advisor and advocate whose reputation in the market attracts a larger, better-vetted buyer pool. That depth compounds into stronger outcomes. The firm never represents the buyer, so its incentives stay aligned with the selling dentist.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>Is It Hard To Sell A Dental Practice?<\/h3>\n<p>Difficulty depends heavily on preparation and representation. A well-priced, well-documented premier practice with professional sell-side representation and multiple competing buyers is generally straightforward to sell. Demand for Class A practices remains strong, and competitive processes regularly produce offers at or above asking price. Difficulty rises sharply for practices that are overpriced, owner-dependent, or exposed to a single buyer with no fallback. The controllable factors described above, including pricing accuracy, EBITDA documentation, buyer pool size, and representation quality, largely determine which category a practice falls into.<\/p>\n<h3>How Long Does It Take To Sell A Dental Practice?<\/h3>\n<p>For a well-prepared, professionally represented dental practice, the typical listing-to-close timeline is roughly 6 to 12 months. Doctor-to-doctor transactions usually close in 6 to 9 months, and some faster individual-buyer sales complete in about 4 to 8 months. DSO transactions commonly take 9 to 18 months because of multi-layer diligence and complex transaction documents. Less-prepared practices, those with declining collections trends, or those in lower-demand markets can take considerably longer. The single most effective way to compress the timeline is to arrive at market with clean, organized financials, a defensible EBITDA analysis, and a clear asking price, all of which McLerran &amp; Associates builds before the practice goes to market.<\/p>\n<h3>What Percentage Of Dental Practices Sell?<\/h3>\n<p>The answer varies significantly by representation model. Do-it-yourself sellers close at roughly 15\u201320%. The broader industry norm, which includes practices listed through generalist brokers and free-valuation lead-generation firms, runs closer to 35\u201340%. Professionally represented practices with structured, multi-buyer processes close at substantially higher rates. The high-success cohort described earlier reflects this difference. The gap illustrates the difference between listing a practice and actually selling it.<\/p>\n<h3>What Makes A Dental Practice Sale Successful?<\/h3>\n<p>Five factors can be some of the most important determinants of a successful dental practice sale. These include correct pricing anchored to a diligence-grade valuation, competitive tension created by multiple vetted buyers competing simultaneously, buyer qualification for financial strength and post-close fit, EBITDA documentation with every add-back unpacked and defensible before the buyer&#8217;s quality-of-earnings team arrives, and sell-side representation that works both the private-buyer and DSO paths. Practices that score well on all five tend to close closer to or above asking price. Practices that score poorly on even one or two face higher risk of a failed transaction or a re-traded price.<\/p>\n<h3>Do I Need A Broker To Sell My Dental Practice?<\/h3>\n<p>A broker is not legally required, yet the data on DIY close rates around 15\u201320% and re-trade rates, where about 85% of lower-middle-market deals face a post-LOI price adjustment, suggests that going it alone can carry substantial financial risk. The more precise question is what kind of representation serves a premier practice best. A local generalist broker with one or two DSO relationships provides limited market exposure and weaker underwriting. A dental-only sell-side advisor with a structured auction process, a CPA-led valuation, and a vetted national buyer pool provides the competitive tension and diligence defense that can move a seller into the higher-success cohort. For owners of premier practices generating $1 million or more in annual revenue, the difference in outcome, both in transaction rate and in final price, can be significant.<\/p>\n<h2>Conclusion: The Dental Practice Sale Success Rate Is A Range You Influence<\/h2>\n<p>The dental practice sale success rate is a range the seller influences through the decisions made before and during the sale process. Published figures diverge widely because they measure different things under different conditions. The 95% LOI-to-close rate reported by Practice Exchange for its own dental deals, the roughly 35\u201340% industry norm across all listed practices, and the roughly 15\u201320% close rate for do-it-yourself sellers are all directionally accurate. Each one describes a different population.<\/p>\n<p>The levers that move a seller into the higher-success cohort are largely controllable. These include pricing, competition among multiple vetted buyers, documentation that supports a diligence-grade EBITDA figure, and sell-side representation whose incentives align with the seller. McLerran &amp; Associates, the dental-only sell-side advisor and advocate with roughly 2,000 successful practice sales, approximately $2 billion in closed transaction volume, and a published transaction rate in the high-success range, exists to put those levers in the seller&#8217;s hands. That means working both transition pathways in roughly equal measure, giving owners a genuine side-by-side comparison of the private-buyer and DSO paths. Its CPA-led EBITDA analysis is built to survive diligence. Its structured auction process generates around 10 offers in 45 to 60 days. It never represents the buyer, and its only client is the selling dentist.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Start a confidential conversation about your transition with McLerran &amp; Associates<\/a>. Call (512) 900-7989 or email info@dentaltransitions.com, or <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">visit our contact page<\/a>.<\/p>\n<h2>Read Next<\/h2>\n<ul>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/sell-dental-practice-without-broker\">How to Sell Your Dental Practice: A 6-Step Guide<\/a><\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/best-dental-partnership-brokers\">Best Dental Partnership Brokers for Selling My Practice<\/a><\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/dental-practice-sale-without-broker\">Dental Practice Sale Without Broker: Why Owners Lose More<\/a><\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/how-dental-practice-brokers-work\">How Dental Practice Brokers Work: A Seller&#8217;s Guide<\/a><\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/steps-to-sell-dental-practice\">How to Sell a Dental Practice: A Step-by-Step Guide<\/a><\/p>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Wondering if your dental practice will sell? McLerran &#038; Associates breaks down real success rates and the factors you can control to close your sale.<\/p>\n","protected":false},"author":1,"featured_media":383,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-384","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=384"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/384\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/383"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}